SCHEMBL3024792

SCHEMBL3024792

N#Cc1ccc(N[C@H]2CCN(Cc3cccs3)C2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 7/20 0.51
CCR2 P41597 5/20 0.51
ROCK1 Q13464 5/20 0.51
L3MBTL1 Q9Y468 1/20 0.46
DPP4 P27487 3/20 0.41
DRD2 P14416 2/20 0.39
DRD4 P21917 2/20 0.39
DRD3 P35462 2/20 0.39
DRD1 P21728 1/20 0.39
DRD5 P21918 1/20 0.39
ACHE P22303 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5148134 1.00 ROCK2 (0.51) ROCK2CCR2ROCK1L3MBTL1DPP4
SCHEMBL3024088 0.83 ROCK2 (0.39) ROCK2CCR2ROCK1L3MBTL1DPP4
SCHEMBL3032958 0.82 ALDH1A1 (0.40) ROCK2CCR2ROCK1L3MBTL1DPP4
SCHEMBL5140554 0.80 ROCK2 (0.50) ROCK2CCR2ROCK1ACHE
SCHEMBL5027678 0.79 CYP2D6 (0.41) ROCK2CCR2ROCK1DPP4ACHE
SCHEMBL3033895 0.79 CYP2D6 (0.41) ROCK2CCR2ROCK1DPP4ACHE
SCHEMBL5031248 0.77 PGR (0.44) ROCK2CCR2ROCK1DPP4DRD4
SCHEMBL3029883 0.76 PGR (0.53) ROCK2CCR2ROCK1L3MBTL1DPP4
SCHEMBL3034358 0.75 PGR (0.64)
SCHEMBL3024142 0.74 PGR (0.51) DPP4HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216813-A1 PYRROLIDINEANILINES SMITHKLINE BEECHAM CORPORATION 2010-08-26 US disclosed
EP-1954133-A2 PYRROLIDINEANILINES SMITHKLINE BEECHAM CORPORATION (US) 2008-08-13 EP disclosed
WO-2007065093-A2 PYRROLIDINEANILINES SMITHKLINE BEECHAM CORPORATION (US) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216813-A1 PYRROLIDINEANILINES PGF, ARG1, CYP19A1 ROCK2 376/4885CCR2 838/4885ROCK1 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.